Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S RUGGIERI

Showing results (91-100 of 167) with videos related to

Pageof 17
Sort By:
The Journal of Biological Chemistry|March 23, 2001
Phytotoxic protein PcF, purification, characterization, and cDNA sequencing of a novel hydroxyproline-containing factor secreted by the strawberry pathogen Phytophthora cactorumG Orsomando, M Lorenzi, N Raffaelli, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 29, 2008
Synthesis and pharmacological evaluation of 4-phenoxy-1,2,3,4-tetrahydroisoquinolines and 4,5,6,6a-tetrahydrochromeno[2,3,4-de]isoquinolinesG Giorgioni, S Ruggieri, F Claudi, et al.
Cellular and Molecular Life Sciences : CMLS|August 29, 2003
PcF protein from Phytophthora cactorum and its recombinant homologue elicit phenylalanine ammonia lyase activation in tomatoG Orsomando, M Lorenzi, E Ferrari, et al.
Journal of Endocrinological Investigation|February 19, 2005
Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: the impact on bone massG Saggese, G I Baroncelli, T Vanacore, et al.
Journal of Neural Transmission|January 1, 1981
Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic responseA Agnoli, M Baldassarre, S Ruggieri, et al.
European Neurology|January 1, 1976
Absence of relationships between L-dopa plasma levels and therapeutic effect in Parkinson's disease treated with L-dopaS Algeri, S Ruggieri, F Miranda, et al.
Advances in Neurology|January 1, 1983
Abnormal involuntary movements: a study of dopaminergic receptor interactionA Agnoli, S Ruggieri, S Del Roscio, et al.
Biochemistry|March 13, 1990
Evidence for an inhibitory effect exerted by yeast NMN adenylyltransferase on poly(ADP-ribose) polymerase activityS Ruggieri, L Gregori, P Natalini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 7, 2001
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term resultsF Stocchi, L Vacca, M F De Pandis, et al.
Biochemical and Biophysical Research Communications|December 30, 1992
Nuclear matrix-associated NMN adenylyltransferase activity in human placentaE Balducci, M Emanuelli, G Magni, et al.
Pageof 17

Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
The Journal of Biological Chemistry|March 23, 2001
Phytotoxic protein PcF, purification, characterization, and cDNA sequencing of a novel hydroxyproline-containing factor secreted by the strawberry pathogen Phytophthora cactorumG Orsomando, M Lorenzi, N Raffaelli, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 29, 2008
Synthesis and pharmacological evaluation of 4-phenoxy-1,2,3,4-tetrahydroisoquinolines and 4,5,6,6a-tetrahydrochromeno[2,3,4-de]isoquinolinesG Giorgioni, S Ruggieri, F Claudi, et al.
Cellular and Molecular Life Sciences : CMLS|August 29, 2003
PcF protein from Phytophthora cactorum and its recombinant homologue elicit phenylalanine ammonia lyase activation in tomatoG Orsomando, M Lorenzi, E Ferrari, et al.
Journal of Endocrinological Investigation|February 19, 2005
Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: the impact on bone massG Saggese, G I Baroncelli, T Vanacore, et al.
Journal of Neural Transmission|January 1, 1981
Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic responseA Agnoli, M Baldassarre, S Ruggieri, et al.
European Neurology|January 1, 1976
Absence of relationships between L-dopa plasma levels and therapeutic effect in Parkinson's disease treated with L-dopaS Algeri, S Ruggieri, F Miranda, et al.
Advances in Neurology|January 1, 1983
Abnormal involuntary movements: a study of dopaminergic receptor interactionA Agnoli, S Ruggieri, S Del Roscio, et al.
Biochemistry|March 13, 1990
Evidence for an inhibitory effect exerted by yeast NMN adenylyltransferase on poly(ADP-ribose) polymerase activityS Ruggieri, L Gregori, P Natalini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 7, 2001
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term resultsF Stocchi, L Vacca, M F De Pandis, et al.
Biochemical and Biophysical Research Communications|December 30, 1992
Nuclear matrix-associated NMN adenylyltransferase activity in human placentaE Balducci, M Emanuelli, G Magni, et al.
Pageof 17